Mike Matson
Stock Analyst at Needham
(3.03)
# 1,229
Out of 5,179 analysts
564
Total ratings
40.64%
Success rate
0.31%
Average return
Main Sectors:
Stocks Rated by Mike Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Reiterates: Buy | $97 | $69.17 | +40.23% | 37 | Mar 30, 2026 | |
| LUCD Lucid Diagnostics | Reiterates: Buy | $3 | $1.12 | +167.86% | 23 | Mar 26, 2026 | |
| MDT Medtronic | Reiterates: Buy | $120 | $87.14 | +37.71% | 25 | Mar 26, 2026 | |
| KIDS OrthoPediatrics | Maintains: Buy | $26 → $30 | $15.52 | +93.30% | 25 | Feb 27, 2026 | |
| PSNL Personalis | Maintains: Buy | $10 → $12 | $6.34 | +89.27% | 22 | Feb 27, 2026 | |
| VCYT Veracyte | Maintains: Buy | $44 → $48 | $30.01 | +59.95% | 19 | Feb 26, 2026 | |
| ENOV Enovis | Maintains: Buy | $49 → $52 | $21.82 | +138.31% | 17 | Feb 26, 2026 | |
| TFX Teleflex | Maintains: Buy | $138 → $147 | $116.22 | +26.48% | 11 | Feb 26, 2026 | |
| LIVN LivaNova | Maintains: Buy | $64 → $81 | $61.85 | +30.96% | 28 | Feb 25, 2026 | |
| MMSI Merit Medical Systems | Maintains: Buy | $108 → $101 | $68.73 | +46.95% | 33 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $166 → $174 | $99.05 | +75.67% | 15 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $86 | $55.31 | +55.49% | 7 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $15 | $7.19 | +108.62% | 29 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $28.88 | +55.82% | 36 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $88.57 | - | 27 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $58 | $35.29 | +64.35% | 21 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $448 → $454 | $327.44 | +38.65% | 11 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $34.58 | - | 26 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $335.10 | - | 14 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $54.04 | - | 16 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4.25 → $9 | $3.56 | +152.81% | 2 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $75.67 | - | 22 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $13.40 | - | 21 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 | $6.19 | +93.86% | 19 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $177.11 | - | 25 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $124.19 | - | 5 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $219.40 | - | 11 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $220.47 | - | 14 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $42 | $12.29 | +241.74% | 2 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $75 | $83.78 | -10.48% | 1 | Feb 18, 2021 |
Boston Scientific
Mar 30, 2026
Reiterates: Buy
Price Target: $97
Current: $69.17
Upside: +40.23%
Lucid Diagnostics
Mar 26, 2026
Reiterates: Buy
Price Target: $3
Current: $1.12
Upside: +167.86%
Medtronic
Mar 26, 2026
Reiterates: Buy
Price Target: $120
Current: $87.14
Upside: +37.71%
OrthoPediatrics
Feb 27, 2026
Maintains: Buy
Price Target: $26 → $30
Current: $15.52
Upside: +93.30%
Personalis
Feb 27, 2026
Maintains: Buy
Price Target: $10 → $12
Current: $6.34
Upside: +89.27%
Veracyte
Feb 26, 2026
Maintains: Buy
Price Target: $44 → $48
Current: $30.01
Upside: +59.95%
Enovis
Feb 26, 2026
Maintains: Buy
Price Target: $49 → $52
Current: $21.82
Upside: +138.31%
Teleflex
Feb 26, 2026
Maintains: Buy
Price Target: $138 → $147
Current: $116.22
Upside: +26.48%
LivaNova
Feb 25, 2026
Maintains: Buy
Price Target: $64 → $81
Current: $61.85
Upside: +30.96%
Merit Medical Systems
Feb 25, 2026
Maintains: Buy
Price Target: $108 → $101
Current: $68.73
Upside: +46.95%
Feb 25, 2026
Maintains: Buy
Price Target: $166 → $174
Current: $99.05
Upside: +75.67%
Feb 24, 2026
Maintains: Buy
Price Target: $84 → $86
Current: $55.31
Upside: +55.49%
Feb 17, 2026
Maintains: Buy
Price Target: $14 → $15
Current: $7.19
Upside: +108.62%
Feb 12, 2026
Reiterates: Buy
Price Target: $45
Current: $28.88
Upside: +55.82%
Feb 10, 2026
Reiterates: Hold
Price Target: n/a
Current: $88.57
Upside: -
Feb 2, 2026
Reiterates: Buy
Price Target: $58
Current: $35.29
Upside: +64.35%
Jan 30, 2026
Maintains: Buy
Price Target: $448 → $454
Current: $327.44
Upside: +38.65%
Jan 29, 2026
Reiterates: Hold
Price Target: n/a
Current: $34.58
Upside: -
Jan 16, 2026
Downgrades: Hold
Price Target: n/a
Current: $335.10
Upside: -
Dec 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $54.04
Upside: -
Nov 11, 2025
Maintains: Buy
Price Target: $4.25 → $9
Current: $3.56
Upside: +152.81%
Oct 21, 2025
Reiterates: Hold
Price Target: n/a
Current: $75.67
Upside: -
Oct 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $13.40
Upside: -
May 22, 2025
Upgrades: Buy
Price Target: $12
Current: $6.19
Upside: +93.86%
Apr 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $177.11
Upside: -
Apr 8, 2025
Reiterates: Hold
Price Target: n/a
Current: $124.19
Upside: -
Apr 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $219.40
Upside: -
Jan 31, 2025
Reiterates: Hold
Price Target: n/a
Current: $220.47
Upside: -
May 4, 2021
Maintains: Buy
Price Target: $34 → $42
Current: $12.29
Upside: +241.74%
Feb 18, 2021
Maintains: Buy
Price Target: $65 → $75
Current: $83.78
Upside: -10.48%